These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 31782831)

  • 1. High P4HA1 expression is an independent prognostic factor for poor overall survival and recurrent-free survival in head and neck squamous cell carcinoma.
    Li Q; Shen Z; Wu Z; Shen Y; Deng H; Zhou C; Liu H
    J Clin Lab Anal; 2020 Mar; 34(3):e23107. PubMed ID: 31782831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Potential Diagnostic and Prognostic Values of
    Li M; Wu F; Zheng Q; Wu Y; Wu Y
    DNA Cell Biol; 2020 May; 39(5):909-917. PubMed ID: 32150689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
    Jin Y; Yang Y
    Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P4HA1 expression and function in esophageal squamous cell carcinoma.
    Gou W; Song B; Yang Y
    Medicine (Baltimore); 2023 Dec; 102(51):e36800. PubMed ID: 38134053
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Sato K; Sano D; Takahashi H; Kuwahara T; Aizawa Y; Aoyama J; Nojima Y; Hatano T; Arai Y; Nishimura G; Hatakeyama H; Oridate N
    Anticancer Res; 2023 Jun; 43(6):2571-2582. PubMed ID: 37247900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
    Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P4HA3 promotes head and neck squamous cell carcinoma progression via the WNT/β-catenin signaling pathway.
    Wang Q; Meng D; Shen S; Cao Y; Zhang P; Liu Y; Du L; Li H; Shao C; Dong Q
    Pathol Res Pract; 2024 Aug; 260():155481. PubMed ID: 39053135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
    Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J
    Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
    Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
    Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival.
    Xu X; Li M; Hu J; Chen Z; Yu J; Dong Y; Sun C; Han J
    J Cancer Res Ther; 2018; 14(7):1525-1534. PubMed ID: 30589034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Analysis of the Expression and Prognostic Significance of P4HA1 in Pancreatic Cancer and Construction of a lncRNA-miRNA-P4HA1 Regulatory Axis.
    Hu Z; Song F; Hu Y; Liao T
    Biomed Res Int; 2020; 2020():8877334. PubMed ID: 33415167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of P4HA1 as a prognostic biomarker for high-grade gliomas.
    Hu WM; Zhang J; Sun SX; Xi SY; Chen ZJ; Jiang XB; Lin FH; Chen ZH; Chen YS; Wang J; Yang QY; Guo CC; Mou YG; Chen ZP; Zeng J; Sai K
    Pathol Res Pract; 2017 Nov; 213(11):1365-1369. PubMed ID: 28964577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
    Zhao X; Cui L
    J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
    BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UBE2C promotes the progression of head and neck squamous cell carcinoma.
    Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
    Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter hypermethylation of CD133/PROM1 is an independent poor prognosis factor for head and neck squamous cell carcinoma.
    Hu Z; Liu H; Zhang X; Hong B; Wu Z; Li Q; Zhou C
    Medicine (Baltimore); 2020 Mar; 99(11):e19491. PubMed ID: 32176088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma.
    Zhou Z; Wu W; Li J; Liu C; Xiao Z; Lai Q; Qin R; Shen M; Shi S; Kang M
    BMC Cancer; 2021 Apr; 21(1):395. PubMed ID: 33845800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of epiregulin/amphiregulin expression in recurrent/metastatic head and neck cancer treated with cetuximab.
    Kogashiwa Y; Inoue H; Kuba K; Araki R; Yasuda M; Nakahira M; Sugasawa M
    Head Neck; 2018 Nov; 40(11):2424-2431. PubMed ID: 30302873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics analyses proposed xenotropic and polytropic retrovirus receptor 1 as a potential diagnostic and prognostic biomarker and immunotherapeutic target in head and neck squamous cell carcinoma.
    Wang L
    Auris Nasus Larynx; 2023 Feb; 50(1):134-150. PubMed ID: 35690506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and Possible Molecular Mechanisms of microRNA-205-5p in Patients With Head and Neck Squamous Cell Carcinoma.
    Zhou Z; Liu C; Liu K; Lv M; Li B; Lan Z; Chen W; Kang M
    Technol Cancer Res Treat; 2020; 19():1533033820980110. PubMed ID: 33327871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.